Literature DB >> 8973754

Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis.

E A Holm1, A Randløv, S Strandgaard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973754     DOI: 10.3109/08037059609078075

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


× No keyword cloud information.
  6 in total

Review 1.  Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure.

Authors:  J E Scoble
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

2.  Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.

Authors:  Marie-Claude Fournie-Zaluski; Celine Fassot; Bruno Valentin; Dragan Djordjijevic; Annabelle Reaux-Le Goazigo; Pierre Corvol; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

Review 3.  Aminopeptidase A inhibitors as centrally acting antihypertensive agents.

Authors:  Laurence Bodineau; Alain Frugière; Yannick Marc; Cédric Claperon; Catherine Llorens-Cortes
Journal:  Heart Fail Rev       Date:  2008-01-03       Impact factor: 4.214

4.  Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis.

Authors:  T L Johansen; A Kjaer
Journal:  BMC Nephrol       Date:  2001-05-17       Impact factor: 2.388

Review 5.  TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review.

Authors:  Ye Zixin; Chen Lulu; Zeng Xiangchang; Fang Qing; Zheng Binjie; Luo Chunyang; Rao Tai; Ouyang Dongsheng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

6.  Utilisation and Tolerability of Aliskiren in the Primary Care Setting in England.

Authors:  Abigail L Coughtrie; Claire Doe; Deborah Layton; Saad A W Shakir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-03       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.